logo
Select company
Select metric
$ -5.85MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
29
Sector
67
Industry
84
History
40
$ 4.15Close
$ 3.28 - $ 45.6 52-Week Range
Ticker Information

Ticker

CDIO

Company Name

CARDIO DIAGNOSTICS HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARDIO DIAGNOSTICS HOLDINGS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CDIO - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 381.35K$ -6.23M$ -5.85M
3/31/2025$ 373.33K$ -5.84M$ -5.46M
12/31/2024$ 276.35K$ -8.36M$ -8.09M
9/30/2024$ 253.79K$ -8.14M$ -7.89M
6/30/2024$ 211.5K$ -8.09M$ -7.88M
3/31/2024$ 135.17K$ -9.78M$ -9.65M
12/31/2023$ 111.62K$ -1.64M$ -1.53M
9/30/2023$ 53.8K$ -2.73M$ -2.67M
6/30/2023$ 17.58K$ -2.52M$ -2.5M
3/31/2023$ 0$ -386.94K$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARDIO DIAGNOSTICS HOLDINGS INC's latest trailing twelve months (TTM) EBITDA stands at $ -1.27M.
  • Over the past 5 years, CARDIO DIAGNOSTICS HOLDINGS INC's average EBITDA has been $ -5.22M.
  • The median EBITDA for CARDIO DIAGNOSTICS HOLDINGS INC during this period was $ -5.46M
  • CARDIO DIAGNOSTICS HOLDINGS INC reached its highest EBITDA over the past 5 years at $ -1.27M.
  • The lowest EBITDA recorded by CARDIO DIAGNOSTICS HOLDINGS INC in the same timeframe $ -9.65M

CARDIO DIAGNOSTICS HOLDINGS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
ADTX : ADITXT INC $ -29.78MIBO : IMPACT BIOMEDICAL INC $ -36.2MCELZ : CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC $ -5.65MACXP : ACURX PHARMACEUTICALS INC $ -10MAPVO : APTEVO THERAPEUTICS INC $ -23.76MPMCB : PHARMACYTE BIOTECH INC $ -1.13MGNPX : GENPREX INC $ -17.28MALZN : ALZAMEND NEURO INC $ -6.17MPALI : PALISADE BIO INC $ -11.71MTCRT : ALAUNOS THERAPEUTICS INC $ -3.99M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for CARDIO DIAGNOSTICS HOLDINGS INC is calculated as follows: EBIT [ $ -1.28M ] + DepAmor [ $ 8K ]
(=) EBITDA [ $ -1.27M ]

CDIO - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -9.65M

Minimum

Mar 31, 2024

$ -1.27M

Maximum

Jun 30, 2022

$ -5.22M

Average

$ -5.46M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M